| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Herbert Waldmann | Q1609256 |
| P2093 | author name string | Elena S Reckzeh | |
| P2860 | cites work | Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 |
| Functional properties and genomics of glucose transporters | Q24651540 | ||
| Fundamentals of cancer metabolism | Q26744062 | ||
| Glucose Metabolism in T Cells and Monocytes: New Perspectives in HIV Pathogenesis | Q26747110 | ||
| Role of PFKFB3-driven glycolysis in vessel sprouting | Q28295875 | ||
| Mechanism of inhibition of human glucose transporter GLUT1 is conserved between cytochalasin B and phenylalanine amides | Q28833619 | ||
| WZB117 (2-Fluoro-6-(m-hydroxybenzoyloxy) Phenyl m-Hydroxybenzoate) Inhibits GLUT1-mediated Sugar Transport by Binding Reversibly at the Exofacial Sugar Binding Site | Q30395148 | ||
| Cloning and functional characterization of the human GLUT7 isoform SLC2A7 from the small intestine | Q30829378 | ||
| Novel inhibitors of basal glucose transport as potential anticancer agents | Q33535601 | ||
| The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition. | Q33763006 | ||
| The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function | Q33838591 | ||
| Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine | Q34104182 | ||
| Mechanism of action of cytochalasin B on actin | Q34272923 | ||
| Cytochalasin B binding sites and glucose transport carrier in human erythrocyte ghosts | Q34401852 | ||
| The Warburg Effect: How Does it Benefit Cancer Cells? | Q34509467 | ||
| Cytochalasin B: inhibition of glucose and glucosamine transport | Q34708122 | ||
| Nutrient transport and pathogenesis in selected parasitic protozoa | Q35080823 | ||
| Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells | Q35176105 | ||
| Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers. | Q35928789 | ||
| Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876. | Q36110504 | ||
| Infection with Mycobacterium tuberculosis induces the Warburg effect in mouse lungs | Q36360891 | ||
| A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models | Q36413261 | ||
| Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells | Q36544964 | ||
| Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer | Q37024512 | ||
| Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment | Q37409860 | ||
| Rewiring cellular metabolism via the AKT/mTOR pathway contributes to host defence against Mycobacterium tuberculosis in human and murine cells | Q37456438 | ||
| Normalization of CD4+ T cell metabolism reverses lupus | Q37625717 | ||
| Potential role of sugar transporters in cancer and their relationship with anticancer therapy | Q37779733 | ||
| Tumor suppressor p53 alters host cell metabolism to limit Chlamydia trachomatis infection | Q37842842 | ||
| Chlamydia pneumoniae directly interferes with HIF-1alpha stabilization in human host cells. | Q37859832 | ||
| Enhancement of ATP levels and glucose metabolism during an infection by Chlamydia. NMR studies of living cells | Q37881227 | ||
| Targeting cancer metabolism: a therapeutic window opens | Q37924094 | ||
| The Role of TGF-β Receptors in Fibrosis | Q38026846 | ||
| Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment | Q38698728 | ||
| Blockade of GLUT1 by WZB117 resensitizes breast cancer cells to adriamycin | Q38700466 | ||
| Brucella abortus Induces a Warburg Shift in Host Metabolism That Is Linked to Enhanced Intracellular Survival of the Pathogen | Q38701808 | ||
| Inhibition of Glut1 by WZB117 sensitizes radioresistant breast cancer cells to irradiation | Q38783426 | ||
| Identification of novel GLUT inhibitors | Q38788418 | ||
| Cutting Edge: Mycobacterium tuberculosis Induces Aerobic Glycolysis in Human Alveolar Macrophages That Is Required for Control of Intracellular Bacillary Replication | Q38908535 | ||
| Glucose-dependent glucose transporter 1 expression and its impact on viability of thyroid cancer cells | Q38928961 | ||
| Overcoming 5-Fu resistance of colon cells through inhibition of Glut1 by the specific inhibitor WZB117. | Q38955980 | ||
| Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer | Q39024340 | ||
| Anticancer agents interacting with membrane glucose transporters | Q39064468 | ||
| A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo. | Q39332797 | ||
| Legionella pneumophila Modulates Mitochondrial Dynamics to Trigger Metabolic Repurposing of Infected Macrophages | Q40068970 | ||
| The Warburg effect in mycobacterial granulomas is dependent on the recruitment and activation of macrophages by interferon-γ. | Q41385584 | ||
| Expression of the rat GLUT1 glucose transporter in the yeast Saccharomyces cerevisiae | Q41855433 | ||
| Glycolysis in patients with age-related macular degeneration | Q41905242 | ||
| Gene expression of GLUT3 glucose transporter regulated by glucose in vivo in mouse brain and in vitro in neuronal cell cultures from rat embryos | Q41946935 | ||
| T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. | Q42134773 | ||
| SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma | Q42366620 | ||
| Expression of glucose transporters in head-and-neck tumors. | Q42505365 | ||
| Profibrotic up-regulation of glucose transporter 1 by TGF-β involves activation of MEK and mammalian target of rapamycin complex 2 pathways. | Q42705478 | ||
| GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker. | Q42787448 | ||
| GLUT1 and GLUT3 as potential prognostic markers for Oral Squamous Cell Carcinoma | Q43081367 | ||
| Metabolic profiling of lung granuloma in Mycobacterium tuberculosis infected guinea pigs: ex vivo 1H magic angle spinning NMR studies | Q44531578 | ||
| Effects of cytochalasin B in culture and in vivo on murine Madison 109 lung carcinoma and on B16 melanoma. | Q44998691 | ||
| Mammalian facilitative glucose transporters: evidence for similar substrate recognition sites in functionally monomeric proteins | Q48418596 | ||
| Over-expression of facilitative glucose transporter genes in human cancer | Q48932689 | ||
| Detection and Characterization of CD8+ Autoreactive Memory Stem T Cells in Patients with Type 1 Diabetes | Q50420770 | ||
| Modeling cancer glycolysis under hypoglycemia, and the role played by the differential expression of glycolytic isoforms. | Q51080469 | ||
| Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis. | Q52584555 | ||
| Reactive Oxygen Species-Mediated Tumor Microenvironment Transformation: The Mechanism of Radioresistant Gastric Cancer. | Q54939968 | ||
| Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors. | Q55481614 | ||
| The Circadian Clock Regulates Metabolic Phenotype Rewiring Via HKDC1 and Modulates Tumor Progression and Drug Response in Colorectal Cancer | Q56958863 | ||
| Chromopynones are pseudo natural product glucose uptake inhibitors targeting glucose transporters GLUT-1 and -3 | Q57006537 | ||
| Targeting ulcerative colitis by suppressing glucose uptake with ritonavir | Q57462248 | ||
| The role of cellular reactive oxygen species in cancer chemotherapy | Q58081811 | ||
| Transcriptional activation of glucose transporter 1 in orthodontic tooth movement-associated mechanical response | Q58778474 | ||
| Rhinovirus induces an anabolic reprogramming in host cell metabolism essential for viral replication | Q59357390 | ||
| Expression of hypoxia-related glucose transporters GLUT1 and GLUT3 in benign, malignant and non-neoplastic thyroid lesions | Q62691948 | ||
| Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer | Q64070907 | ||
| Control of glucose metabolism is important in tenogenic differentiation of progenitors derived from human injured tendons | Q64082306 | ||
| A chemical toolbox for the study of bromodomains and epigenetic signaling | Q64097709 | ||
| Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced β-catenin activation | Q64290667 | ||
| Kinetics of interferon-gamma secretion and its regulatory factors in the early phase of acute graft-versus-host disease | Q73232001 | ||
| Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival | Q73717523 | ||
| Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy | Q77557069 | ||
| Targeting Key Transporters in Tumor Glycolysis as a Novel Anticancer Strategy | Q88776347 | ||
| Quercetin inhibits glucose transport by binding to an exofacial site on GLUT1 | Q88951221 | ||
| Mechanisms of antimelanoma effect of oat β-glucan supported by electroporation | Q89179492 | ||
| Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation | Q89288769 | ||
| Inhibition of GLUTs by WZB117 mediates apoptosis in blood-stage Plasmodium parasites by breaking redox balance | Q89313795 | ||
| Influence of glucose transporter 1 activity inhibition on neuroblastoma in vitro | Q90558732 | ||
| Cytosolic Aspartate Availability Determines Cell Survival When Glutamine Is Limiting | Q91025752 | ||
| Inhibition of Glucose Transporters and Glutaminase Synergistically Impairs Tumor Cell Growth | Q91863715 | ||
| The combination of the glycolysis inhibitor 2-DG and sorafenib can be effective against sorafenib-tolerant persister cancer cells | Q92354463 | ||
| Discovery of Small-Molecule Selective mTORC1 Inhibitors via Direct Inhibition of Glucose Transporters | Q92969237 | ||
| Synthesis of Indomorphan Pseudo-Natural Product Inhibitors of Glucose Transporters GLUT-1 and -3 | Q93008067 | ||
| Membrane-enriched solute carrier family 2 member 1 (SLC2A1/GLUT1) in psoriatic keratinocytes confers sensitivity to 2-deoxy-D-glucose (2-DG) treatment | Q93337404 | ||
| P433 | issue | 1-2 | |
| P304 | page(s) | 45-52 | |
| P577 | publication date | 2019-11-08 | |
| P1433 | published in | ChemBioChem | Q634395 |
| P1476 | title | Small-Molecule Inhibition of Glucose Transporters GLUT-1-4 | |
| P478 | volume | 21 |
Search more.